Ulrike Leiter-Stöppke

23PUBLICATIONS
91CO-AUTHORS
Solid tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 07, 2026
S1 guideline sweat gland carcinoma.

|Feb 27, 2026
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma.

Michael Weichenthal, Dirk Debus, Lisa Zimmer

|Jan 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis.

Glenn Geidel, Sabrina Bänsch, Laura Adam

|Nov 06, 2025
Messages for ultraviolet-radiation protection to fair-skinned populations.

Lieve Brochez, Claus Garbe, Teresa Amaral

|Apr 25, 2025
Psychosocial distress and persistent adverse events in long-term survivors of stage IV melanoma - a cross-sectional questionnaire study.

Markus Reitmajer, Norbert Schäffeler, Anne Bach

|Mar 22, 2025
Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma.

Dirk Tomsitz, Elisabeth Livingstone, Carmen Loquai

Pageof 4

Frequent Collaborators

8 joint publications

Claus Garbe

8 joint publications

Markus V Heppt

7 joint publications

Dirk Schadendorf

6 joint publications

Teresa Amaral